Dapagliflozin And Metformin Hydrochloride 00310-6350-00
- Manufacturer
- Astrazeneca Pharmaceuticals Lp
- Dosage Form
- Tablet, Film Coated, Extended Release
- Product Type
- Drug For Further Processing
- Marketing Start
- May 19, 2022
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dapagliflozin Propanediol | 5 mg/1 |
| Metformin Hydrochloride | 500 mg/1 |
Selected Package
00310-6350-00Selected180000 TABLET, FILM COATED, EXTENDED RELEASE in 1 DRUM (0310-6350-00)